(Reuters) - Cipla Ltd, India's second-biggest drugmaker by market capitalization, posted a fourth-quarter profit on Tuesday, but missed analysts' estimates.
Net profit came in at 1.79 billion rupees ($26.30 million) for the quarter ended March 31, compared with a loss of 617.9 million rupees in the year-ago quarter, the company said https://www.bseindia.com/xml-data/corpfiling/AttachLive/2d0d0d7f-af2e-4011-839a-9d5e84a05a76.pdf.
Analysts, on average, had expected a profit of 3.57 billion rupees, according to Thomson Reuters data.
Also Read
($1 = 68.0650 Indian rupees)
(Reporting By Arnab Paul in Bengaluru; Editing by Vyas Mohan)
Disclaimer: No Business Standard Journalist was involved in creation of this content
